Rare Summit 2025: Julián Vega Adauy brings cardiac MR and T1 mapping to the Fabry disease symposium in Buenos Aires

Anderson-Fabry disease had a chapter of its own at the Latin American Rare Disease Summit “Visión de Futuro” (Rare Summit 2025), held by Sanofi on August 28 and 29, 2025 in Buenos Aires, Argentina. At the Fabry symposium, on the morning of Friday the 29th, Dr. Julián Vega Adauy, INCIC cardiologist and cardiac imaging specialist, gave the talk “Role of CMR + T1 mapping in Anderson-Fabry disease”.

The audience brought together some 60 physicians from across Latin America, most of them treating physicians with experience in the disease: mainly nephrologists and cardiologists, along with pediatricians, geneticists and neurologists. A multidisciplinary audience, just like the care of patients with Fabry disease.

In a 20-minute slot within a clinical case module, the talk covered the role of cardiac magnetic resonance in diagnosing and following the disease, the value of T1 mapping to characterize myocardial tissue, and the Chilean experience with the NGS genetic panel. As the organizers requested, it drew on patient images, like the cine, T1 map and late enhancement sequences shown with this article.

Dr. Vega Adauy closed his talk with FABRYTON Chile 2025, the project that would bring cardiac MR to patients with Fabry disease in northern Chile, at the Antofagasta Regional Hospital, in October that year (see the event).

His participation reflects a core line of work at INCIC: putting advanced cardiac MR, with parametric mapping and protocols tailored to each clinical question, at the service of rare diseases.